Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moneeza Walji

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Medicine, Conflict, and Survival|August 7, 2009
Environmental health risks and vulnerability in post-conflict regionsChad M Briggs, Moneeza Walji, Lucy Anderson
Bone Marrow Transplantation|October 4, 2025
Real-world experience of belumosudil and belumosudil/ruxolitinib combination in steroid-refractory chronic graft-versus-host diseaseGagan Raju, Moneeza Walji, David Nemirovsky, et al.
Bone Marrow Transplantation|March 30, 2026
Correction: Real-world experience of belumosudil and belumosudil/ruxolitinib combination in steroid-refractory chronic graft-versus-host diseaseGagan Raju, Moneeza Walji, David Nemirovsky, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|March 9, 2016
Upholding the integrity of your CMAJDiane Kelsall, Kirsten Patrick, Matthew B Stanbrook, et al.
Transplantation and Cellular Therapy|July 11, 2025
Insurance Barriers to High-Cost Anti-Infective Medications Post Allogeneic Hematopoietic Cell TransplantStephen Eng, Grashma Vadakkel, Samantha Brown, et al.
Blood Cancer Journal|November 25, 2025
Allogeneic hematopoietic cell transplantation in acute myeloid leukemia not in complete remission: outcomes and prognostic factors in a contemporary cohortShlomo Elias, Samantha Brown, Ogechukwu Egini, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|April 12, 2018
The effectiveness and cost-effectiveness of screening for latent tuberculosis among migrants in the EU/EEA: a systematic reviewChristina Greenaway, Manish Pareek, Claire-Nour Abou Chakra, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|April 12, 2018
The effectiveness and cost-effectiveness of screening for active tuberculosis among migrants in the EU/EEA: a systematic reviewChristina Greenaway, Manish Pareek, Claire-Nour Abou Chakra, et al.
Transplantation and Cellular Therapy|November 7, 2022
Allogeneic Hematopoietic Cell Transplantation after Chimeric Antigen Receptor T Cell Therapy in Large B Cell LymphomaShalev Fried, Roni Shouval, Moneeza Walji, et al.
Haematologica|November 21, 2024
Predictors and implications of renal injury after CD19 chimeric antigen receptor T-cell therapyAlexander P Boardman, Victoria Gutgarts, Jessica Flynn, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Medicine, Conflict, and Survival|August 7, 2009
Environmental health risks and vulnerability in post-conflict regionsChad M Briggs, Moneeza Walji, Lucy Anderson
Bone Marrow Transplantation|October 4, 2025
Real-world experience of belumosudil and belumosudil/ruxolitinib combination in steroid-refractory chronic graft-versus-host diseaseGagan Raju, Moneeza Walji, David Nemirovsky, et al.
Bone Marrow Transplantation|March 30, 2026
Correction: Real-world experience of belumosudil and belumosudil/ruxolitinib combination in steroid-refractory chronic graft-versus-host diseaseGagan Raju, Moneeza Walji, David Nemirovsky, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|March 9, 2016
Upholding the integrity of your CMAJDiane Kelsall, Kirsten Patrick, Matthew B Stanbrook, et al.
Transplantation and Cellular Therapy|July 11, 2025
Insurance Barriers to High-Cost Anti-Infective Medications Post Allogeneic Hematopoietic Cell TransplantStephen Eng, Grashma Vadakkel, Samantha Brown, et al.
Blood Cancer Journal|November 25, 2025
Allogeneic hematopoietic cell transplantation in acute myeloid leukemia not in complete remission: outcomes and prognostic factors in a contemporary cohortShlomo Elias, Samantha Brown, Ogechukwu Egini, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|April 12, 2018
The effectiveness and cost-effectiveness of screening for latent tuberculosis among migrants in the EU/EEA: a systematic reviewChristina Greenaway, Manish Pareek, Claire-Nour Abou Chakra, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|April 12, 2018
The effectiveness and cost-effectiveness of screening for active tuberculosis among migrants in the EU/EEA: a systematic reviewChristina Greenaway, Manish Pareek, Claire-Nour Abou Chakra, et al.
Transplantation and Cellular Therapy|November 7, 2022
Allogeneic Hematopoietic Cell Transplantation after Chimeric Antigen Receptor T Cell Therapy in Large B Cell LymphomaShalev Fried, Roni Shouval, Moneeza Walji, et al.
Haematologica|November 21, 2024
Predictors and implications of renal injury after CD19 chimeric antigen receptor T-cell therapyAlexander P Boardman, Victoria Gutgarts, Jessica Flynn, et al.
Pageof 3